Laparoscopy Robot Articles & Analysis
13 news found
On-demand robotics is a new technique for laparoscopic surgery. It has been used in Germany for the first time by the Department for Women’s Health and Gynecology at the University Hospital Tübingen. Together with the University Hospital Tübingen we announced today the successful completion of gynecological surgeries using Dexter®. This marks Dexter’s first clinical ...
Surgeons at Lausanne University Hospital (CHUV) perform the world’s first hybrid robotic general surgery. Distalmotion and CHUV announce the launch of a clinical study. The CHUV’s Division for Visceral Surgery is at the forefront of establishing a new standard of patient care, and will become a global reference center for hybrid robotic surgery with Dexter. Distalmotion and ...
PISA, Italy. June 8.2022 - Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in "THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS). REFERENCE: CPI-2019-33-1-TRE-14. in the framework of the Line for the Promotion of Innovation from the Demand for the Public ...
BOSTON — May 24, 2022 — Activ Surgical™, a digital surgery pioneer, today announced the successful completion of an Institutional Review Board (IRB) study using its ActivSight™ intraoperative imaging module at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB) in New York. The 40-patient study was led by principal investigator Dr. ...
Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Arizona Urology, a comprehensive urological care center with three physician offices in the surrounding Phoenix area. Promaxo’s single-sided MRI with AI based imaging system, FDA cleared for in-office use, ...
Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Beverly Hills Urology. Promaxo’s single-sided MRI with AI based imaging system, FDA cleared for in-office use, empowers practices and hospitals to accurately and seamlessly guide prostate interventions under the ...
Dexter is coming to Italy. Together with NBA Medica we plan to make robotics more accessible, user-friendly and versatile for Italian surgeons in the fields of general surgery, gynecology and urology. Left to right: Cristiano Fontana, Head of Business Development at NBA Medica and Marco Sesenna, CEO NBA Medica, in Lausanne at Distalmotion HQ with Dexter. ©Distalmotion Distalmotion has ...
Distalmotion, Revival Healthcare Capital and 415 CAPITAL announce the closing of a USD 90 million Series E financing round to accelerate the adoption of Distalmotion’s surgical robot Dexter. The investment follows Dexter’s successful initial clinical use and supports Distalmotion’s international commercial scaling. More than capital: A partnership of medtech pioneers and ...
Senior leadership in sales, R&D and operations including new chief commercial officer positions Memic for growth and success as company launches Hominis® surgical robot Tel Aviv, Israel and Fort Lauderdale, FL, November 15, 2021 – Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Shinmatsudo Central General Hospital in Matsudo, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are excited to partner with ...
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the fourth quarter and full-year 2020. Recent Highlights Senhance Surgical System received expanded 510(k) clearance for general ...
The new Cellvizio®platform includes significant improvements and will enable major innovations Mauna Kea Technologies announced today that it has obtained 510(k) clearance (K193416) from the U.S. Food and Drug Administration (FDA) and CE marking of the next-generation Cellvizio® endomicroscopy platform, built with the company’s new proprietary system architecture. This marks the ...
The Cellvizio®100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image blood flow in the microvasculature and capillaries Mauna Kea Technologies today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Cellvizio® 100 series and all associated Confocal Miniprobes™ for ...